Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

scientific article published on 18 May 2013

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TOXLET.2013.05.006
P698PubMed publication ID23694763

P2093author name stringLi Zhang
Jing Huang
Bing Yang
Guosheng Ren
Tingxiu Xiang
Xuedong Yin
Hongyuan Li
Hongzhong Li
Jingyuan Wan
Fuling Luo
P2860cites workInhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice.Q40451449
P433issue3
P921main subjecttriple-negative breast cancerQ7843332
P304page(s)219-228
P577publication date2013-05-18
P1433published inToxicology LettersQ1796854
P1476titleNaringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway
P478volume220

Reverse relations

cites work (P2860)
Q46653563Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats.
Q34177531Anticancer activities of citrus peel polymethoxyflavones related to angiogenesis and others
Q93351725Antioxidant capacity and UPLC-PDA ESI-MS polyphenolic profile of Citrus aurantium extracts obtained by ultrasound assisted extraction
Q28066511Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?
Q48243050Chiral separation of novel iminonaringenin derivatives
Q39429454Dietary Natural Products for Prevention and Treatment of Breast Cancer.
Q52911940Flavonoids of Korean Citrus aurantium L. Induce Apoptosis via Intrinsic Pathway in Human Hepatoblastoma HepG2 Cells.
Q94544661Mapping Pharmacological Network of Multi-Targeting Litchi Ingredients in Cancer Therapeutics
Q94453355Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway
Q46753154Naringin inhibits gamma radiation-induced oxidative DNA damage and inflammation, by modulating p53 and NF-κB signaling pathways in murine splenocytes
Q90043146Naringin sensitizes human prostate cancer cells to paclitaxel therapy
Q38827105Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src
Q60935782Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis
Q53646650Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Q28546685Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors
Q59055781Pharmacological Activities of Sijunzi Decoction Which Are Related to Its Antioxidant Properties
Q33710002Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
Q51745517Polymeric micelles for potentiated antiulcer and anticancer activities of naringin.
Q91837396Potential anticancer applications of the novel naringin-based ruthenium (II) complex
Q46547518Supercritical Fluid Extraction of Citrus iyo Hort. ex Tanaka Pericarp Inhibits Growth and Induces Apoptosis Through Abrogation of STAT3 Regulated Gene Products in Human Prostate Cancer Xenograft Mouse Model
Q40745223Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio.